Michael Thomas

7PUBLICATIONS
19CO-AUTHORS
Genomics and transcriptomicsCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 04, 2026
Decoding efficacy and resistance space at a drug binding site.

Simone Altmann, Cesar Mendoza-Martinez, Melanie Ridgway

|Jul 02, 2025
Structure-activity relationships of 1,5-dihydro-2H-benzo[b][1,4]diazepine-2,4(3H)-diones as inhibitors of Trypanosoma cruzi.

Michael G Thomas, Joanne Dunne, Peter G Dodd

|Jul 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors.

Michael G Thomas, Kate McGonagle, Paul Rowland

|Mar 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis.

Alasdair Smith, Richard J Wall, Stephen Patterson

|Apr 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis.

Michael Thomas, Stephen Brand, Manu De Rycker

|Jan 22, 2021
Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis.

Michael G Thomas, Manu De Rycker, Myriam Ajakane

Pageof 2

Frequent Collaborators

6 joint publications

Manu De Rycker

4 joint publications

Maria Marco

4 joint publications

Kevin D Read

4 joint publications

Timothy J Miles